Back to
BNP Paribas Financial Markets
QNCX
27 quarters
Position history for
BNP Paribas Financial Markets's holdings in QUINCE THERAPEUTICS INC
As of its Q1 2026 13F, BNP Paribas Financial Markets held 8 shares of QNCX (Quince Therapeutics), worth $1. BNP Paribas Financial Markets' 13F filings listed QNCX from Q2 2025 to Q1 2026, 4 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$595
Total Shares Change
-14
Quarter-by-Quarter History
Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors